HDAC inhibitor derivatives induce differentiation of leukemic cells through two distinct and separable mechanisms
Preprint
Kumar P. et al, (2024)
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.
Journal article
Brimblecombe KR. et al, (2023), Eur J Neurosci
Kinetic insights into agonist-dependent signalling bias at the pro-inflammatory G-protein coupled receptor GPR84.
Journal article
Luscombe VB. et al, (2023), Eur J Pharmacol, 956
A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2.
Journal article
Bery N. et al, (2021), Sci Adv, 7
The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes.
Journal article
Hua P. et al, (2020), Blood, 136, 2410 - 2415
Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase family.
Journal article
Quevedo CE. et al, (2020), Bioorg Med Chem, 28
20 Years an Orphan: Is GPR84 a Plausible Medium-Chain Fatty Acid-Sensing Receptor?
Journal article
Luscombe VB. et al, (2020), DNA Cell Biol, 39, 1926 - 1937
NMR waterLOGSY as An Assay in Drug Development Programmes for Detecting Protein-Ligand Interactions-NMR waterLOGSY.
Journal article
Bataille CJR. et al, (2020), Bio Protoc, 10
Anthelmintic drug discovery: target identification, screening methods and the role of open science.
Journal article
Partridge FA. et al, (2020), Beilstein J Org Chem, 16, 1203 - 1224
Immunopolymer Lipid Nanoparticles for Delivery of Macromolecules to Antigen-Expressing Cells
Journal article
Jain AK. et al, (2020), ACS Applied Bio Materials
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson’s
Journal article
Brimblecombe K. et al, (2020)
A Biased Agonist at Immunometabolic Receptor GPR84 Causes Distinct Functional Effects in Macrophages.
Journal article
Lucy D. et al, (2019), ACS Chem Biol, 14, 2055 - 2064
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds.
Journal article
Cruz-Migoni A. et al, (2019), Proc Natl Acad Sci U S A, 116, 2545 - 2550
Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX Inhibitors.
Journal article
Stefaniak J. et al, (2018), ACS Chem Biol, 13, 2849 - 2854
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment.
Journal article
Quevedo CE. et al, (2018), Nat Commun, 9
Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions.
Journal article
Bery N. et al, (2018), Elife, 7
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions.
Journal article
Bery N. et al, (2018), Elife, 7
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-Effector protein-protein interactions
Journal article
Bery N. et al, (2018), eLife, 7